Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2
SARS-CoV-2 病毒样颗粒疫苗单价和双价制剂的免疫原性和有效性
期刊:Vaccines
影响因子:
doi:10.3390/vaccines10121997
Matthew D Resch, Ke Wen, Ryan Mazboudi, Hannah Mulhall Maasz, Mirjana Persaud, Kaitlyn Garvey, Leslie Gallardo, Paul Gottlieb, Aleksandra Alimova, Reza Khayat, Jorge Morales, Helle Bielefeldt-Ohmann, Richard A Bowen, Jose M Galarza
